Bogdan Socea, Alexandru Carap, Ovidiu Gabriel Bratu, Camelia Cristina Diaconu, Mihai Dimitriu, Laura Ileana Socea, Simona Bobic, Vlad Denis Constantin - The Role of the Composite and Biologic Meshes in the Trocar Site Hernia Repair Following Laparoscopic Surgery
18 October 2018 in The International Conference on Advanced Materials and Systems
Background/Objectives: Synthetic mesh repair of abdominal wall hernias can be complicated by infection, often requiring mesh removal. Bioactive coatings may enable local antimicrobial delivery while preserving mesh properties. This study developed a synthetic surgical mesh coated with a minocycline hydrochloride (MH)-loaded type I fibrillar collagen gel, evaluated MH concentration and coating layer effects, optimized the formulation, and assessed preliminary in vivo tolerability and wound healing. Methods: Collagen gel containing MH was applied to meshes by repeated immersion/drying (1–3 layers) using a Mitchell-Bayne 32 design. Meshes were characterized by optical microscopy, SEM, contact angle, enzymatic degradation, and MH release, and in vivo clinical trials were conducted in 20 Wistar rats using superficial excisional and thermal injury models. Results: SEM proved collagen/MH deposition. The meshes with 0.6% MH showed the highest enzymatic resistance. Release was rapid in the first 60 min and then gradual; the Power law model fitted best (R2 > 0.97), indicating non-Fickian release. The mesh coated with two layers of collagen consisting of 0.6% MH promoted faster wound closure than controls: complete re-epithelialization by day 5 for superficial wounds, and complete thermal wound healing by day 10. No macroscopic local intolerance or systemic adverse reactions occurred. Conclusions: The MH-loaded collagen-coated textile mesh provided controlled local drug delivery, enzymatic stability, and preliminary wound-healing benefits with good local tolerability.
Background/Objectives: Breast cancer is the most commonly diagnosed malignancy among women, with hormone receptor-positive tumors representing the majority of cases. Increasing survival rates have shifted attention toward long-term complications, including the risk of secondary malignancies. Emerging evidence suggests a potential association between breast cancer and gastrointestinal (GI) neoplasia. This study aimed to evaluate the role of colonoscopic and upper gastrointestinal endoscopic monitoring in patients with ER/PR-positive breast cancer and to assess its potential value in the early detection of digestive lesions. Methods: We conducted a prospective observational study including 186 female patients with histologically confirmed ER/PR-positive breast cancer. A total of 95 patients underwent colonoscopy, and 91 patients underwent upper gastrointestinal endoscopy. Clinical, demographic, and risk factor data were collected. A structured questionnaire was used to assess gastrointestinal symptoms. Endoscopic findings, lesion characteristics, and histopathological results were recorded. Bowel preparation quality was assessed using the Boston Bowel Preparation Scale. Results: Colonoscopy identified polyps and other lesions, with the majority located in the rectum and descending colon. A total of 12 biopsies were performed, revealing 1 malignant lesion, 2 borderline lesions, and the remainder benign. Upper gastrointestinal endoscopy showed gastritis as the most frequent finding, followed by gastric ulcers and polyps, while most patients had normal endoscopic results. Overall, 72% of patients presented at least one risk factor for digestive malignancy. Following treatment, most patients reported improvement in gastrointestinal symptoms. Conclusions: Patients with ER/PR-positive breast cancer may present a higher prevalence of gastrointestinal lesions, potentially related to shared risk factors and the systemic effects of endocrine therapy. Targeted, symptom-oriented endoscopic evaluation may facilitate early detection of premalignant and malignant digestive conditions. A multidisciplinary, risk-adapted surveillance approach should be considered to improve patient outcomes. Further large-scale studies are required to establish evidence-based screening strategies in this population.